Piperidyl acrylamide antagonists of CCR2
    5.
    发明授权
    Piperidyl acrylamide antagonists of CCR2 有权
    CCR2的哌啶基丙烯酰胺拮抗剂

    公开(公告)号:US08188287B2

    公开(公告)日:2012-05-29

    申请号:US12487742

    申请日:2009-06-19

    IPC分类号: C07D401/00 A61K31/445

    CPC分类号: C07D209/14 C07D403/12

    摘要: The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R4, R5 and X are as defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is uveitis, including acute, recurring or chronic uveitis. The invention also comprises a method of inhibiting CCR2 activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

    摘要翻译: 本发明包括式I化合物,其中:R1,R2,R3,R4,R5和X如说明书中所定义。 本发明还包括治疗或改善综合征,病症或疾病的方法,其中所述综合征,病症或疾病是葡萄膜炎,包括急性,复发性或慢性葡萄膜炎。 本发明还包括通过施用治疗有效量的至少一种式I化合物来抑制哺乳动物CCR2活性的方法。